{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:02:47Z","timestamp":1791079367597,"version":"4.1.0"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rho GTPase-effector mammalian diaphanous (mDia)\u2013related formins assemble nonbranched actin filaments as part of cellular processes, including cell division, filopodia assembly, and intracellular trafficking. Whereas recent efforts have led to thorough characterization of formins in cytoskeletal remodeling and actin assembly in vitro, little is known about the role of mDia proteins in vivo. To fill this knowledge gap, the Drf1 gene, which encodes the canonical formin mDia1, was targeted by homologous recombination. Upon birth, Drf1+\/\u2212 and Drf1\u2212\/\u2212 mice were developmentally and morphologically indistinguishable from their wild-type littermates. However, both Drf1+\/\u2212 and Drf1\u2212\/\u2212 developed age-dependent myeloproliferative defects. The phenotype included splenomegaly, fibrotic and hypercellular bone marrow, extramedullary hematopoiesis in both spleen and liver, and the presence of immature myeloid progenitor cells with high nucleus-to-cytoplasm ratios. Analysis of cell surface markers showed an age-dependent increase in the percentage of CD11b+-activated and CD14+-activated monocytes\/macrophages in both spleen and bone marrow in Drf1+\/\u2212 and Drf1\u2212\/\u2212 animals. Analysis of the erythroid compartment showed a significant increase in the proportion of splenic cells in S phase and an expansion of erythroid precursors (TER-119+ and CD71+) in Drf1-targeted mice. Overall, knocking out mDia1 expression in mice leads to a phenotype similar to human myeloproliferative syndrome (MPS) and myelodysplastic syndromes (MDS). These observations suggest that defective DRF1 expression or mDia1 function may contribute to myeloid malignancies and point to mDia1 as an attractive therapeutic target in MDS and MPS. [Cancer Res 2007;67(16):7565\u201371]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1467","type":"journal-article","created":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T19:18:10Z","timestamp":1187205490000},"page":"7565-7571","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Myeloproliferative Defects following Targeting of the <i>Drf1<\/i> Gene Encoding the Mammalian Diaphanous\u2013Related Formin mDia1"],"prefix":"10.1158","volume":"67","author":[{"given":"Jun","family":"Peng","sequence":"first","affiliation":[{"name":"1Laboratory of Cell Structure and Signal Integration and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Kitchen","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Structure and Signal Integration and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"West","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Structure and Signal Integration and"},{"name":"2Flow Cytometry Core Facility, Van Andel Research Institute, Grand Rapids, Michigan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sigler","sequence":"additional","affiliation":[{"name":"3Esperion Therapeutics, Division of Pfizer, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Eisenmann","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Structure and Signal Integration and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Alberts","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Structure and Signal Integration and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"key":"2022061623341990600_B1","doi-asserted-by":"crossref","unstructured":"Goode BL, Eck MJ. Mechanism and Function of Formins in Control of Actin Assembly. Annu Rev Biochem\u20082007; 76: 593\u2013627.","DOI":"10.1146\/annurev.biochem.75.103004.142647"},{"key":"2022061623341990600_B2","doi-asserted-by":"crossref","unstructured":"Wallar BJ, Alberts AS. The formins: active scaffolds that remodel the cytoskeleton. Trends Cell Biol\u20082003; 138: 435\u201346.","DOI":"10.1016\/S0962-8924(03)00153-3"},{"key":"2022061623341990600_B3","doi-asserted-by":"crossref","unstructured":"Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol\u20081999; 13: 136\u201343.","DOI":"10.1038\/11056"},{"key":"2022061623341990600_B4","doi-asserted-by":"crossref","unstructured":"Alberts AS. Identification of a carboxyl-terminal diaphanous-related formin homology protein autoregulatory domain. J Biol Chem\u20082001; 2764: 2824\u201330.","DOI":"10.1074\/jbc.M006205200"},{"key":"2022061623341990600_B5","doi-asserted-by":"crossref","unstructured":"Lynch ED, Lee MK, Morrow JE, Welcsh PL, Leon PE, King MC. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous [see comments]. Science\u20081997; 2785341: 1315\u20138.","DOI":"10.1126\/science.278.5341.1315"},{"key":"2022061623341990600_B6","doi-asserted-by":"crossref","unstructured":"Higgs HN. Formin proteins: a domain-based approach. Trends Biochem Sci\u20082005; 306: 342\u201353.","DOI":"10.1016\/j.tibs.2005.04.014"},{"key":"2022061623341990600_B7","doi-asserted-by":"crossref","unstructured":"Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet\u20081998; 623: 533\u201341.","DOI":"10.1086\/301761"},{"key":"2022061623341990600_B8","doi-asserted-by":"crossref","unstructured":"Peng J, Wallar BJ, Flanders A, Swiatek PJ, Alberts AS. Disruption of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an effector for Cdc42. Curr Biol\u20082003; 137: 534\u201345.","DOI":"10.1016\/S0960-9822(03)00170-2"},{"key":"2022061623341990600_B9","doi-asserted-by":"crossref","unstructured":"Watanabe N, Madaule P, Reid T, et al. p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J\u20081997; 1611: 3044\u201356.","DOI":"10.1093\/emboj\/16.11.3044"},{"key":"2022061623341990600_B10","doi-asserted-by":"crossref","unstructured":"Swiatek PJ, Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev\u20081993; 711: 2071\u201384.","DOI":"10.1101\/gad.7.11.2071"},{"key":"2022061623341990600_B11","doi-asserted-by":"crossref","unstructured":"Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer\u20082007; 72: 118\u201329.","DOI":"10.1038\/nrc2047"},{"key":"2022061623341990600_B12","doi-asserted-by":"crossref","unstructured":"Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol\u20082003; 4210: 761\u201378.","DOI":"10.1046\/j.1365-4362.2003.01891.x"},{"key":"2022061623341990600_B13","doi-asserted-by":"crossref","unstructured":"Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature\u20082005; 4377055: 147\u201353.","DOI":"10.1038\/nature03915"},{"key":"2022061623341990600_B14","doi-asserted-by":"crossref","unstructured":"Royer-Pokora B, Trost D, Muller N, Hildebrandt B, Germing U, Beier M. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia. Cancer Genet Cytogenet\u20082006; 1671: 66\u20139.","DOI":"10.1016\/j.cancergencyto.2005.08.003"},{"key":"2022061623341990600_B15","doi-asserted-by":"crossref","unstructured":"Liu TX, Becker MW, Jelinek J, et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding \u03b1-catenin (CTNNA1) in myeloid cell transformation. Nat Med\u20082007; 131: 78\u201383.","DOI":"10.1038\/nm1512"},{"key":"2022061623341990600_B16","doi-asserted-by":"crossref","unstructured":"Horrigan SK, Arbieva ZH, Xie HY, et al. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood\u20082000; 957: 2372\u20137.","DOI":"10.1182\/blood.V95.7.2372.007k20_2372_2377"},{"key":"2022061623341990600_B17","doi-asserted-by":"crossref","unstructured":"Joslin JM, Fernald AA, Tennant TR, et al. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood\u20082007; 110: 719\u201326.","DOI":"10.1182\/blood-2007-01-068809"},{"key":"2022061623341990600_B18","doi-asserted-by":"crossref","unstructured":"Janssen-Timmen U, Lemaire P, Mattei MG, Revelant O, Charnay P. Structure, chromosome mapping and regulation of the mouse zinc-finger gene Krox-24; evidence for a common regulatory pathway for immediate-early serum-response genes. Gene\u20081989; 802: 325\u201336.","DOI":"10.1016\/0378-1119(89)90296-5"},{"key":"2022061623341990600_B19","doi-asserted-by":"crossref","unstructured":"Gineitis D, Treisman R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem\u20082001; 27627: 24531\u20139.","DOI":"10.1074\/jbc.M102678200"},{"key":"2022061623341990600_B20","doi-asserted-by":"crossref","unstructured":"Tominaga T, Sahai E, Chardin P, McCormick F, Courtneidge SA, Alberts AS. Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Molecular Cell\u20082000; 51: 13\u201325.","DOI":"10.1016\/S1097-2765(00)80399-8"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/16\/7565\/2571982\/7565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/16\/7565\/2571982\/7565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:50:49Z","timestamp":1655437849000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/16\/7565\/533351\/Myeloproliferative-Defects-following-Targeting-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":20,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2007,8,15]]},"published-print":{"date-parts":[[2007,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1467","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}